Cargando…

A novel diabetes typology: towards precision diabetology from pathogenesis to treatment

The current classification of diabetes, based on hyperglycaemia, islet-directed antibodies and some insufficiently defined clinical features, does not reflect differences in aetiological mechanisms and in the clinical course of people with diabetes. This review discusses evidence from recent studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Herder, Christian, Roden, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522691/
https://www.ncbi.nlm.nih.gov/pubmed/34981134
http://dx.doi.org/10.1007/s00125-021-05625-x
_version_ 1784800113132044288
author Herder, Christian
Roden, Michael
author_facet Herder, Christian
Roden, Michael
author_sort Herder, Christian
collection PubMed
description The current classification of diabetes, based on hyperglycaemia, islet-directed antibodies and some insufficiently defined clinical features, does not reflect differences in aetiological mechanisms and in the clinical course of people with diabetes. This review discusses evidence from recent studies addressing the complexity of diabetes by proposing novel subgroups (subtypes) of diabetes. The most widely replicated and validated approach identified, in addition to severe autoimmune diabetes, four subgroups designated severe insulin-deficient diabetes, severe insulin-resistant diabetes, mild obesity-related diabetes and mild age-related diabetes subgroups. These subgroups display distinct patterns of clinical features, disease progression and onset of comorbidities and complications, with severe insulin-resistant diabetes showing the highest risk for cardiovascular, kidney and fatty liver diseases. While it has been suggested that people in these subgroups would benefit from stratified treatments, RCTs are required to assess the clinical utility of any reclassification effort. Several methodological and practical issues also need further study: the statistical approach used to define subgroups and derive recommendations for diabetes care; the stability of subgroups over time; the optimal dataset (e.g. phenotypic vs genotypic) for reclassification; the transethnic generalisability of findings; and the applicability in clinical routine care. Despite these open questions, the concept of a new classification of diabetes has already allowed researchers to gain more insight into the colourful picture of diabetes and has stimulated progress in this field so that precision diabetology may become reality in the future. GRAPHICAL ABSTRACT: [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-021-05625-x) contains peer-reviewed but unedited supplementary material including a slide of the figure for download, which is available to authorised users.
format Online
Article
Text
id pubmed-9522691
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-95226912022-10-01 A novel diabetes typology: towards precision diabetology from pathogenesis to treatment Herder, Christian Roden, Michael Diabetologia Review The current classification of diabetes, based on hyperglycaemia, islet-directed antibodies and some insufficiently defined clinical features, does not reflect differences in aetiological mechanisms and in the clinical course of people with diabetes. This review discusses evidence from recent studies addressing the complexity of diabetes by proposing novel subgroups (subtypes) of diabetes. The most widely replicated and validated approach identified, in addition to severe autoimmune diabetes, four subgroups designated severe insulin-deficient diabetes, severe insulin-resistant diabetes, mild obesity-related diabetes and mild age-related diabetes subgroups. These subgroups display distinct patterns of clinical features, disease progression and onset of comorbidities and complications, with severe insulin-resistant diabetes showing the highest risk for cardiovascular, kidney and fatty liver diseases. While it has been suggested that people in these subgroups would benefit from stratified treatments, RCTs are required to assess the clinical utility of any reclassification effort. Several methodological and practical issues also need further study: the statistical approach used to define subgroups and derive recommendations for diabetes care; the stability of subgroups over time; the optimal dataset (e.g. phenotypic vs genotypic) for reclassification; the transethnic generalisability of findings; and the applicability in clinical routine care. Despite these open questions, the concept of a new classification of diabetes has already allowed researchers to gain more insight into the colourful picture of diabetes and has stimulated progress in this field so that precision diabetology may become reality in the future. GRAPHICAL ABSTRACT: [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-021-05625-x) contains peer-reviewed but unedited supplementary material including a slide of the figure for download, which is available to authorised users. Springer Berlin Heidelberg 2022-01-04 2022 /pmc/articles/PMC9522691/ /pubmed/34981134 http://dx.doi.org/10.1007/s00125-021-05625-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Herder, Christian
Roden, Michael
A novel diabetes typology: towards precision diabetology from pathogenesis to treatment
title A novel diabetes typology: towards precision diabetology from pathogenesis to treatment
title_full A novel diabetes typology: towards precision diabetology from pathogenesis to treatment
title_fullStr A novel diabetes typology: towards precision diabetology from pathogenesis to treatment
title_full_unstemmed A novel diabetes typology: towards precision diabetology from pathogenesis to treatment
title_short A novel diabetes typology: towards precision diabetology from pathogenesis to treatment
title_sort novel diabetes typology: towards precision diabetology from pathogenesis to treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522691/
https://www.ncbi.nlm.nih.gov/pubmed/34981134
http://dx.doi.org/10.1007/s00125-021-05625-x
work_keys_str_mv AT herderchristian anoveldiabetestypologytowardsprecisiondiabetologyfrompathogenesistotreatment
AT rodenmichael anoveldiabetestypologytowardsprecisiondiabetologyfrompathogenesistotreatment
AT herderchristian noveldiabetestypologytowardsprecisiondiabetologyfrompathogenesistotreatment
AT rodenmichael noveldiabetestypologytowardsprecisiondiabetologyfrompathogenesistotreatment